Next Article in Journal
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets
Next Article in Special Issue
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Monotherapy Compared with Combination Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis
Previous Article in Journal
New Approaches to Targeting Epigenetic Regulation in Bladder Cancer
Previous Article in Special Issue
Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant
 
 
Review

Article Versions Notes

Cancers 2023, 15(6), 1857; https://doi.org/10.3390/cancers15061857
Action Date Notes Link
article xml file uploaded 20 March 2023 08:13 CET Original file -
article xml uploaded. 20 March 2023 08:13 CET Update https://www.mdpi.com/2072-6694/15/6/1857/xml
article pdf uploaded. 20 March 2023 08:13 CET Version of Record https://www.mdpi.com/2072-6694/15/6/1857/pdf
article html file updated 20 March 2023 08:14 CET Original file -
article html file updated 6 April 2023 20:58 CEST Update https://www.mdpi.com/2072-6694/15/6/1857/html
Back to TopTop